Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

4.75
Delayed Data
As of May 05
 -0.26 / -5.19%
Today’s Change
3.55
Today|||52-Week Range
23.39
-54.24%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close5.01
Today’s open5.05
Day’s range4.65 - 5.06
Volume205,018
Average volume (3 months)240,256
Market cap$172.6M
Dividend yield--
Data as of 05/05/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio97.1
Price/Sales9.15
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
--Wang On Group Ltd+0.00+12.50%
ASTAsterias Biotherapeu...+0.04+0.90%
CBMGCellular Biomedicine...-0.11-0.72%
SZYMSolazyme Inc-0.07-3.20%
Data as of 05/05/2016

Financials

Last reporting dateMay 6, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers

Search for Jobs